Aug 2026· Molecular and Cellular Endocrinology· Vol 622, pp.
112880
· 0 citations· 40 references
Medicine
TL;DR
Findings suggest that IP3R may exacerbate cardiomyocyte injury by facilitating MAM-mediated Ca2+ transfer and mitochondrial dysfunction, indicating that targeting IP3R could represent a potential therapeutic strategy for HF.
Abstract
Background
Heart failure (HF) is the terminal stage of various cardiovascular diseases. Mitochondrial Ca2+ overload and dysfunction mediated by mitochondria-associated ER membranes (MAMs) are recognized contributors to HF pathogenesis; however, the underlying molecular mechanisms remain incompletely understood.
Methods
An in vitro model of cardiomyocyte injury was established using angiotensin II (Ang II)-stimulated H9c2 cells. IP3R was knocked down using specific siRNA. Cell viability (CCK-8), apoptosis (Annexin V/TUNEL), and hypertrophy (phalloidin staining) were assessed. IP3R expression and mitochondrial complex subunits were analyzed by western blotting. MAM formation was examined by transmission electron microscopy and immunofluorescence co-localization. Mitochondrial function was evaluated by measuring ATP levels, ROS (MitoSOX), mitochondrial membrane potential (TMRM), and Ca2+ uptake (Rhod-2).
Results
Ang II stimulation reduced cell viability, induced hypertrophy and apoptosis, and promoted MAM formation. Mechanistically, Ang II upregulated IP3R expression and enhanced MAM-mediated mitochondrial Ca2+ overload, leading to decreased mitochondrial membrane potential, elevated ROS, and reduced ATP production. Notably, genetic knockdown of IP3R attenuated these pathological changes, reducing MAM formation and mitochondrial Ca2+ overload while restoring mitochondrial function and cell viability.
Conclusion
Our findings suggest that IP3R may exacerbate cardiomyocyte injury by facilitating MAM-mediated Ca2+ transfer and mitochondrial dysfunction, indicating that targeting IP3R could represent a potential therapeutic strategy for HF. However, the upstream mechanisms of IP3R upregulation and the causal role of mitochondrial Ca2+ uptake require further investigation.
Observations support a model in which Netrin-3 participates in coupling inflammasome signaling to mitochondrial alterations through a ROS-dependent route, and whether Netrin-3 inhibition has therapeutic value in heart failure warrants further investigation.
Biao Li, Hao-Yang Ge, Xi-Wei Chen et al.· International Immunopharmaco...· 0 citations
Findings identify MFN2 as a potential regulator of MAM-mediated mitochondrial calcium homeostasis in SIM and suggest it may represent a therapeutic target for sepsis-induced skeletal muscle dysfunction.
Xue-Xin Li, Fei He, Yun Wang et al.· Skeletal Muscle· 0 citations
OBJECTIVE
To investigate the role of Src tyrosine kinase in Zn2+-induced cardioprotection and the mechanisms involving endoplasmic reticulum stress (ERS), mitochondrial dysfunction, and mitochondrial calcium regulation.
METHODS
H9c2 cells were used to establish in vitro models of ischemia/reperfusion (I/R) injury and...
Intracranial aneurysms (IAs) are a significant cause of morbidity and mortality, often leading to subarachnoid hemorrhage and subsequent neurological deficits. The kinase insert domain receptor (KDR) plays a crucial role in vascular cell function during IA. However, the mechanism responsible for KDR’s role in IA remain...
Y. Shao, Zheng-Xiang Yang, Yi Pu et al.· Applied Biological Chemistry· 0 citations
It is suggested that CARD10 deficiency is associated with enhanced fibroblast senescence and improved post-MI remodeling, potentially involving mitochondrial dysfunction and PI3K/AKT signaling, highlighting CARD10 may represent a promising target for the treatment of MI.
Yueyue Xu, Yiwei Yao, Yue-Yun Zhou et al.· The Journal of Cardiovascula...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.